Literature DB >> 17493582

Complete inactivation of Venezuelan equine encephalitis virus by 1,5-iodonaphthylazide.

Anuj Sharma1, Yossef Raviv, Anu Puri, Mathias Viard, Robert Blumenthal, Radha K Maheshwari.   

Abstract

Hydrophobic alkylating compounds like 1,5-iodonaphthylazide (INA) partitions into biological membranes and accumulates selectively into the hydrophobic domain of the lipid bilayer. Upon irradiation with far UV light, INA binds selectively to transmembrane proteins in the viral envelope and renders them inactive. Such inactivation does not alter the ectodomains of the membrane proteins thus preserving the structural and conformational integrity of immunogens on the surface of the virus. In this study, we have used INA to inactivate Venezuelan equine encephalitis virus (VEEV). Treatment of VEEV with INA followed by irradiation with UV light resulted in complete inactivation of the virus. Immuno-fluorescence for VEEV and virus titration showed no virus replication in-vitro. Complete loss of infectivity was also achieved in mice infected with INA treated plus irradiated preparations of VEEV. No change in the structural integrity of VEEV particles were observed after treatment with INA plus irradiation as assessed by electron microscopy. This data suggest that such inactivation strategies can be used for developing vaccine candidates for VEEV and other enveloped viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493582     DOI: 10.1016/j.bbrc.2007.04.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1).

Authors:  Julie M Belanger; Yossef Raviv; Mathias Viard; M Jason de la Cruz; Kunio Nagashima; Robert Blumenthal
Journal:  Virology       Date:  2011-07-02       Impact factor: 3.616

3.  Characterization of the effects of aryl-azido compounds and UVA irradiation on the viral proteins and infectivity of human immunodeficiency virus type 1.

Authors:  Julie M Belanger; Yossef Raviv; Mathias Viard; Michael Jason de la Cruz; Kunio Nagashima; Robert Blumenthal
Journal:  Photochem Photobiol       Date:  2010 Sep-Oct       Impact factor: 3.421

4.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Authors:  Donald L Fine; Erin Jenkins; Shannon S Martin; Pamela Glass; Michael D Parker; Brad Grimm
Journal:  J Virol Methods       Date:  2009-11-10       Impact factor: 2.014

5.  HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.

Authors:  Amy Jacobs; Himanshu Garg; Mathias Viard; Yossef Raviv; Anu Puri; Robert Blumenthal
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

6.  Orthogonal inactivation of influenza and the creation of detergent resistant viral aggregates: towards a novel vaccine strategy.

Authors:  Julie M Belanger; Yossef Raviv; Mathias Viard; Ulrich Baxa; Robert Blumenthal
Journal:  Virol J       Date:  2012-03-26       Impact factor: 4.099

7.  Inactivation of non-enveloped virus by 1,5 iodonaphthyl azide.

Authors:  Paridhi Gupta; Anuj Sharma; Viard Mathias; Yossef Raviv; Robert Blumenthal; Radha K Maheshwari
Journal:  BMC Res Notes       Date:  2015-02-15

8.  Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.

Authors:  Shelley P Honnold; Russell R Bakken; Diana Fisher; Cathleen M Lind; Jeffrey W Cohen; Lori T Eccleston; Kevin B Spurgers; Radha K Maheshwari; Pamela J Glass
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

9.  Inactivation of Chikungunya virus by 1,5 iodonapthyl azide.

Authors:  Anuj Sharma; Paridhi Gupta; Radha K Maheshwari
Journal:  Virol J       Date:  2012-12-04       Impact factor: 4.099

10.  Photo-activation of the hydrophobic probe iodonaphthylazide in cells alters membrane protein function leading to cell death.

Authors:  Mathias Viard; Himanshu Garg; Robert Blumenthal; Yossef Raviv
Journal:  BMC Cell Biol       Date:  2009-03-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.